GTC Biotherapeutics (fka GTCB)

[n4807g]

OK....we continue to focus on the single trial. My only concern going forward isn't the trial. Certainly a successful outcome would make a better case for a partnership in the USA and Japan and provide needed funds. The "fog" in front of my eyes is the lack of a partnership to exploit the platform. I assume that the primary reason we haven't seen this angle fully exploited is a function of the need for congress to put forward a Bill that clears the way for F.O.B's.

If/when that happens GTC becomes a very valuable company.